Xevo G3 QTof
Complete coverage for confident characterization
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
All my equipment should be Waters Todos mis equipos deberían ser Waters
Pharmaceuticals
Waters always has excellent service. The equipment is not only highly functional, it also has an excellent design. Waters siempre tiene un servicio de excelencia. Los equipos no solo son altamente funcionales, también tienen un excelente diseño.
Review Date: 24 May 2023 | Waters
Overall it is a great instrument with high precision, multiple uses and good performance
Protein The characterization and identification in milk, cholostrum and semen, antibodies
Xevo is very effective and in our area of application. Result reproducibility is slightly difficult may be a issue at user end in sample prep. Also one issue is that it is difficult to analyze data produced by this instrument in any other related external software. overall a great beast!
Review Date: 7 Feb 2023 | Waters
Maximize sample information for your analytes from detailed characterization to accurate quantitation with the Xevo G3 QTof, which enables complete confidence in your results.
The latest generation of the Xevo product line extends the simplicity and range of characterization, from challenging small molecules to complex biotherapeutics. Updates to the ion optics design provide consistent robustness and performance, with incorporation of core technology for comprehensive quantitation capabilities. Centered around an expanding array of informatics tools, the Xevo G3 QTof has your lab covered.
Overview:
- Ultimate performance: Ensure maximum coverage of analytes, with improved transmission of low mass labile species, while still excelling in traditional biopharmaceutical workflows and addressing emerging needs to characterize new modalities.
- Connected productivity: Harmonize workflows across development, manufacturing and monitoring/quality control (QC) with the waters_connect ecosystem, Xevo G3 QTof, and BioAccord System with ACQUITY Premier.
- Extended flexibility: Improve quantitative capabilities, with wider inter- and intra-spectrum dynamic range for comprehensive quantitative/qualitative analysis, ideal for screening and targeted applications.
- Unquestioned confidence: Achieve consistent data quality and reproducibility to maintain performance and productivity over a longer time period, with updated ion optics.
Recommended Use:Characterize and quantify a diverse set of molecules on a single, analytical workhorse.
Brochures
Harmonize your biopharmaceutical (LC/MS) workflows
In this infographic, Waters introduces its Xevo™ G3 QTof System, an analytical workhorse for the detailed characterization of biomolecules and processes.
Addressing the global challenge of PFAS contamination
Per- and polyfluoroalkyl substances (PFAS) are a class of synthetic chemicals that pose significant environmental and health challenges due to their persistence and bioaccumulation. PFAS testing is one of the most pressing issues facing analytical labs today. As global attention grows, so does the demand for reliable answers.
Technologies such as liquid chromatography-tandem mass spectrometry (LC-MS/ MS) and high-resolution mass spectrometry (HRMS) can be essential for assessing PFAS contamination accurately. Discover how advanced LC-MS/MS and HRMS technologies are helping scientists and regulators tackle PFAS challenges head-on.
From sample preparation to data analysis, explore how Waters Corporation provides the tools needed to measure, manage, and mitigate the impact of PFAS, driving scientific progress and regulatory compliance.
Markers for COVID-19 disease progression: Comprehensive LC-MS characterization of the metabolome with the Xevo G3 QTof
During this webinar you’ll learn about the recently launched Xevo G3 QTof system and discover how it's solving problems that matter.
Professor Clare Mills discusses the use of an LC/MS metabolomics approach to profile serum from COVID-19 inpatients. Here they describe how to identify and characterize prognostic biomarkers to support the development of mass spectrometry rapid clinical screening tools.
Tune in to hear more about how the team are planning to characterize immune disfunction as a consequence of SARS-CoV-2 infection.
Key learning objectives
- Discover how the new Xevo G3 QTof system provides comprehensive characterization of analytes
- Develop an understanding of LC/MS and its use in metabolomic and lipidomic studies
- Delve into the world of omics, identifying statistically relevant markers for disease and the impact on patients
Who should attend?
- Scientists interested in characterizing a range of analytes with LC/MS
- Lab managers who want high-throughput, benchtop QTof technology that helps solve problems in their lab
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Unlock the future of PFAS detection with high-resolution mass spectrometry
Discover how Waters' HRMS innovations are enhancing the accuracy and scope of PFAS detection and analysis
